Recent Press Releases & News
FBLG earnings at a glance
FibroBiologics, Inc. (FBLG) is scheduled to report earnings on Friday, October 30, 2026 — in 7 days. Analysts expect earnings per share of -$0.63, compared with -$2.60 in the same quarter last year (+76%). Over its last 1 reports the stock rose the next day 0 times and fell 1, moving ±1.0% on average; after the most recent report on May 14, 2025 it moved -1.0%. FBLG beat the consensus EPS estimate in 0 of its last 3 reported quarters. The share price of $1.02 sits near its 52-week low.
Overview
Earnings trends
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.66 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-1.33 | — | — | — | — | financials |
| Fri Oct 31, 2025 | Sep/2025 | $-0.13 | $-0.10 | -30.0% | — | — | earnings |
| Thu Jul 31, 2025 | Jun/2025 | $-0.12 | $-0.11 | -9.1% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.14 | $-0.10 | -40.0% | — | -1.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.01 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.03 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.27 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.08 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.08 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.18 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Fri Oct 30, 2026 | Sep/2026 | OTHER | -$0.63 | -$2.60 | +75.8% |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-5M | — | $-5M | $-4M | $-5M | — | $-3M |
| Net income | $-4M | $-5M | — | $-6M | $-5M | $-5M | — | $-500,000 |
| EPS (diluted) | $-0.66 | $-1.33 | — | $-0.13 | $-2.41 | $-2.71 | — | $-0.01 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $1M | $5M | $5M | $9M | $9M | $14M | $8M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $6M | $3M | $6M | $5M | $10M | $9M | $14M | $8M |
| Total assets | $8M | $6M | $10M | $9M | $14M | $11M | $16M | $10M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3M | $3M | $3M | $9M | $13M | $9M | $14M | $8M |
| Total equity | $5M | $3M | $6M | $125,000 | $860,000 | $2M | $3M | $3M |
Implied volatility — last 90 days
No IV snapshots yet for FBLG.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
FBLG earnings FAQ
When is FBLG's next earnings date?
FibroBiologics, Inc. is expected to report on October 30, 2026.
How does FBLG stock usually react to earnings?
Across the last 1 reports the average next-day move was ±1.0%, up 0 times and down 1 times.
What EPS are analysts expecting from FibroBiologics, Inc.?
The consensus estimate is -$0.63 per share, versus -$2.60 a year ago.